Navigation Links
Bionovo Initiates Menerba (MF101) Phase 3 Clinical Trial for Menopausal Hot Flashes
Date:10/26/2011

EMERYVILLE, Calif., Oct. 26, 2011 /PRNewswire/ -- Bionovo, Inc. (Nasdaq: BNVI), a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today announced that enrollment has started to the Phase 3 pivotal clinical trial evaluating the safety and efficacy of two doses of Menerba™ (MF101) among a cohort of postmenopausal women for the treatment of menopausal hot flashes.

The Phase 3, multicenter, double-blind, placebo-controlled, randomized clinical trial evaluating Menerba is currently open for enrollment. A total of 50 clinical sites in the U.S. will enroll 1,200 postmenopausal women between the ages of 40 and 65 years. Participants will be randomized to Menerba 5g/day, Menerba 10g/day or placebo and treated for 12 weeks. The primary aims of the study are to determine the safety and efficacy of two doses of Menerba compared to placebo after 12 weeks of treatment.  Efficacy will be measured by the reduction of moderate to severe hot flushes from baseline to 12 weeks of treatment. Dr. Wulf Utian, Executive Director Emeritus and Honorary Founding President of the North America Menopause Society and Professor Emeritus at Case Western Reserve University is serving as the Principal Investigator for the study.

"We have had a very busy and productive year preparing for today's important launch of the late stage clinical trial in the field of women's health. As predicted from our vast toxicology data and the mechanism of action, we showed that higher doses of Menerba were very safe and demonstrated a level of efficacy similar to hormone therapy. Today we are proceeding with our first pivotal Phase 3 trial of Menerba with great optimism and enthusiasm. We are elated to be one step closer to providing a truly novel agent for the treatment of menopausal hot flashes to the 40 million women in need of
'/>"/>

SOURCE Bionovo, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Bionovo to Present Tissue Selective Estrogen Receptor Modulators for Obesity at the 22nd Annual Meeting of the North American Menopause Society
2. Bionovo Announces an Additional 180 Day Period to Regain Compliance With Nasdaqs Bid Price Rule
3. CORRECTED: Bionovo Announces Second Quarter 2011 Highlights and Financial Results
4. Bionovo Announces Second Quarter 2011 Highlights and Financial Results
5. Bionovo to Present the Clinical Promise of Menerba (MF101) for Postmenopausal Vasomotor Symptoms at World Congress on Menopause
6. Bionovo to Announce First Quarter Financial Results on Wednesday, May 11, 2011
7. Bionovo Announces Enrollment Started in the Menerba (MF101) Phase 1 "Tolerability" Clinical Trial for Menopausal Hot Flushes
8. Bionovo Announces 2010 Highlights and Year-End Financial Results
9. Bionovo, Inc. to Announce Fourth Quarter Fiscal Year 2010 Financial Results on Tuesday, March 15, 2011
10. Bionovo to Present at the Cowen and Company 31st Annual Healthcare Conference
11. Bionovo Announces 2011 Plan of Action on MF101 (Menerba™)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... , July 6, 2015 ... of Cellvizio®, the multidisciplinary confocal laser endomicroscopy platform, ... Japan,s Ministry of Health, Labor ... Laser Endomicroscopy solution, the AQ-Flex 19 miniprobe.   ... AQ -Flex™ 19 miniprobe is comprised of a ...
(Date:7/6/2015)... Calif. , July 6, 2015  Protiviti, a ... 2015 Internal Auditing around the World publication ... has analyzed and reported on the evolution of the ... from around the globe as a means to providing ... understanding of this strategic business function. The ...
(Date:7/6/2015)... Research and Markets( http://www.researchandmarkets.com/research/58tdl6/pharmaceutical ... Grade Sodium Chloride Market by Applications, by Region - ... their offering. The pharmaceutical grade sodium chloride ... between 2014 and 2019 in terms of volume, and ... 2019. The report on Pharmaceutical grade sodium ...
Breaking Medicine Technology:Mauna Kea Technologies Receives Regulatory Approval for the AQ-Flex 19 Miniprobe in Japan 2Mauna Kea Technologies Receives Regulatory Approval for the AQ-Flex 19 Miniprobe in Japan 3New Edition of Internal Auditing Around the World from Protiviti Explores Changes and Trends 2Global Pharmaceutical Grade Sodium Chloride Market Report 2015 2Global Pharmaceutical Grade Sodium Chloride Market Report 2015 3
... and LONDON, April 14 Rib-X,Pharmaceuticals, Inc. ("Rib-X" ... discovery and development of novel antibiotics for,the treatment ... of the Medical Research Council (MRC) today announced,they ... area of,ribosome and antibiotic structure and function for ...
... who,purchased raw milk from Beulah Land Jerseys in ... it immediately due to the risk of,Listeria Monocytogenes ... milk is milk that has not been pasteurized ... permitted and have samples of,their milk laboratory tested ...
Cached Medicine Technology:Rib-X Pharmaceuticals Renews Collaborative Agreement with the Medical Research Council 2
(Date:7/6/2015)... ... 2015 , ... Olive Fertility Centre is proud to announce that Olive medical ... behalf of the department of Family Practice. , “This award is a real honour,” ... The technology is changing so rapidly and we are also developing new models of ...
(Date:7/6/2015)... , ... July 06, 2015 , ... Seedstock today announced ... keynote address at the 4th Annual Seedstock Sustainable Agriculture Conference – “Innovation and the ... conference , held at the University of California-San Diego, will explore solutions and methodologies ...
(Date:7/6/2015)... ... July 06, 2015 , ... With a new community ... with Livonia Save Our Youth and announced a new charity campaign to raise funds ... to alcohol and drug abuse. Livonia Save Our Youth is a coalition created especially ...
(Date:7/6/2015)... VA (PRWEB) , ... July 06, 2015 , ... ... that Dr. Jeffrey R. Carlson finished his 100th case using SpineFrontier’s® PedFuse® REmind® ... Mary Immaculate Hospital in Newport News, VA. The procedure was an L5-S1 posterior ...
(Date:7/5/2015)... ... ... City Sports, the Boston-based specialty sporting goods retailer, has renewed their partnership with ... summer with ethos, the owner and operator of the Boston Triathlon. , The first ... the North End Greenway. The event will help new triathletes prepare for the transition ...
Breaking Medicine News(10 mins):Health News:Olive Fertility Centre Physician Honoured for Teaching 2Health News:Seedstock Names Go Green Agriculture Founder and CEO as 2015 Sustainable Agriculture Conference Keynote Speaker 2Health News:Seedstock Names Go Green Agriculture Founder and CEO as 2015 Sustainable Agriculture Conference Keynote Speaker 3Health News:Seedstock Names Go Green Agriculture Founder and CEO as 2015 Sustainable Agriculture Conference Keynote Speaker 4Health News:Bowker Insurance Group and Nonprofit Livonia Save Our Youth Initiate New Charity Campaign in Livonia, MI to Provide for The Health and Safety of The Communities’ Youth 2Health News:Bowker Insurance Group and Nonprofit Livonia Save Our Youth Initiate New Charity Campaign in Livonia, MI to Provide for The Health and Safety of The Communities’ Youth 3Health News:100th Outpatient Less Exposure Surgery Procedure Completed by Industry Leading Surgeon Dr. Jeffrey Carlson 2Health News:100th Outpatient Less Exposure Surgery Procedure Completed by Industry Leading Surgeon Dr. Jeffrey Carlson 3Health News:Sporting Goods Retailer City Sports Renews Partnership with Boston Triathlon 2Health News:Sporting Goods Retailer City Sports Renews Partnership with Boston Triathlon 3
... Statins might fight deadly pulmonary disease, experts say , , FRIDAY, ... blood cholesterol also slow the lung function loss that inevitably ... smoking, researchers report. , The Harvard study included a group ... measured at least twice between 1995 and 2005. , Those ...
... sprays and air fresheners as little as once a ... adults, say researchers in Europe. Such products have been ... a similar effect in nonprofessional users has never before ... sprays may be an important risk factor for adult ...
... Magnetic resonance images (MRI) of a large group of patients ... with a history of MS in their families show more ... with the disease. , The results, based on brain MRIs ... patients genetic make-up plays a role not only in development ...
... 12 Don,t hire an ad agency; at,least not initially ... is not because an agency can,t come up with something ... new marketing ideas. Most clients follow tradition process in ... interview agencies, then develop a,short list of 3 agencies and ...
... (SEND2PRESS NEWSWIRE) --,OCuSOFT Inc., producer of the ... OCuSOFT(R) Lid Scrub(TM) PLUS, is responding,to a ... (AVR) that,was found to be misleading. ... bacteria time-kill analysis, compared OCuSOFT,s Lid,Scrub(TM) PLUS ...
... Oct. 11 Sutter Health and an agency,that ... violating state law --,and jeopardizing public health -- ... legal competency validation to be working in hospitals ... California Nurses,Association/National Nurses Organizing Committee today. In ...
Cached Medicine News:Health News:Anti-Cholesterol Drugs Help Prevent Lung Decline 2Health News:Even occasional use of spray cleaners may cause asthma in adults 2Health News:MS that runs in families appears more severe than non-familial MS 2Health News:MS that runs in families appears more severe than non-familial MS 3Health News:A New Way to Discover Marketing Ideas 2Health News:OCuSOFT Refutes Comparison Time-Kill Study Released by Advanced Vision Research 2Health News:Sutter Violating State Safety Laws on Assuring Proper Competency Validation of Strike Staff, Say RNs 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: